| ENTITY |
POTENCY |
SAFETY_INFORMATION |
EVIDENCE |
PMID |
| Multivalent Glycosylated Nanostructures | Ebola virus (EBOV) infection | | However, new tridecafullerenes-in which the central alkyne scaffold of [60]fullerene is connected to 12 sugar-containing [60]fullerene units (total 120 mannoses)-exhibit an outstanding antiviral activity with IC50 in the sub-nanomolar range! The multivalent presentation of specific carbohydrates by using 3D fullerenes as controlled biocompatible carbon scaffolds represents a real advance, being currently the most efficient molecules in vitro against EBOV infection. | 28394600 |
| Metal oxide microspheres | An antiviral activity higher than 2 log of reduction was also observed on H1N1 and HSV-1 viruses | | Antimicrobial activity of metal oxide microspheres: an innovative process for homogeneous incorporation into materials. | 29502354 |
| BSA-nano-Ag | Potent anti-TB drug | | Nature-inspired novel drug design paradigm using nanosilver: efficacy on multi-drug-resistant clinical isolates of tuberculosis. | 20936471 |
| Copper Oxide Nanomaterial Derived from Momordica charantia | Activity against R2B virus | | Besides, the therapeutic potential of CuO NRs against Corynebacterium xerosis, Streptococcus viridians and R2B strain of Newcastle disease is reported for the first time. | 32368039 |
